Cargando…
Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells
SIMPLE SUMMARY: Alternative splicing (AS) is one of the hallmarks of human cancer. One of the most common mechanisms of vemurafenib resistance in malignant melanoma is AS of BRAF, occurring in 15–30% of patients. The aim of our study was to investigate the transcriptome and AS D04landscape in the is...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312936/ https://www.ncbi.nlm.nih.gov/pubmed/35883549 http://dx.doi.org/10.3390/biom12070993 |